FidoCure
PrivateLast Round
Series A
Extension
Jul 18, 2022
Total Funding Raised
$15M
Company Overview
FidoCure operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A Extension round in July 2022.
FidoCure is a veterinary oncology company that provides personalized medicine services to deliver advanced cancer care for dogs, utilizing DNA sequencing to identify genetic mutations and recommend targeted therapies for effective treatment.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FidoCure Comparables
Compare FidoCure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImpriMed, Inc. | 87% | |
| VetOmics | 85% | |
| Anivive Lifesciences | 84% |
For institutional investors. Book with your work email.
FidoCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 18, 2022 | ||||
| Series A | Oct 29, 2020 | ||||
| Seed | Jan 23, 2019 | ||||
| Seed | Jan 31, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FidoCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Seed |
| Bossa Invest | Series A Extension |
| Benjamin Franklin Technology Partners | Seed |
| Spark Growth Ventures | Series A |
| Global Brain Corporation | Series A Extension |
| Tau Ventures | Seed, Series A |
| Y Combinator | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2019
$5M round led by Andreessen Horowitz
For institutional investors. Book with your work email.
FidoCure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FidoCure's valuation, stock price, and market status.
Is FidoCure a public or private company?
FidoCure is a private company.
What is the current stock price of FidoCure?
FidoCure is a private company, so its shares have no public market price. Caplight tracks FidoCure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FidoCure worth (valuation)?
Valuation information for FidoCure is not publicly available.
Can I buy FidoCure stock?
FidoCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FidoCure's last funding round?
FidoCure's most recent funding round was Series A Extension on July 18, 2022.
Who are the main investors in FidoCure?
Key investors in FidoCure include Andreessen Horowitz, Global Brain Corporation, Borealis Ventures, Polaris Partners.
Will FidoCure IPO soon?
No public IPO plans have been announced for FidoCure.
How can I track FidoCure secondary market activity?
Caplight tracks bids, offers, and trades in FidoCure's shares on secondary markets.